Episode 121: Home Infusion of Antineoplastics During COVID-19
Lisa Kennedy-Sheldon, PhD, ANP-BC, AOCNP®, FAAN, ONS clinical and scientific affairs liaison, joins Chelsea Backler, MSN, APRN, AGCNS-BC, AOCNS®, ONS oncology clinical specialist and former home care nurse, to discuss how the COVID-19 coronavirus pandemic affects antineoplastics administration and safety considerations for in-home cancer care. More information is available in ONS’s recent position statement, linked in the episode notes.
This episode is supported by an educational grant from Genentech, a member of the Roche Group. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.
Episode Notes
Check out these resources from today’s episode:
- The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.
- ONS position statement: Infusion of Antineoplastic Therapies in the Home
- Oncology Nursing Podcast Episode 53: Home Care Nursing for Patients With Cancer
- Oncology Nursing Podcast Episode 96: The COVID-19 Coronavirus and Cancer Care
- Oncology Nursing Podcast Episode 97: COVID-19 Cancer Care Lessons From Seattle and New York
- ONS Voice article: Home Care for Patients With Cancer
- ONS Recommendations for Oncology Staff Assignments During the COVID-19 Pandemic
- ONS Interim PPE Guidelines During the COVID-19 Pandemic
- ASCO/ONS Chemotherapy Administration Safety Standards
- American Association of Cancer Research meeting: COVID-19 and Cancer
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Listen on:
Listen on Amazon Music, Listen on Apple Podcasts, Listen on Google Podcasts, Listen on Spotify, Listen on Stitcher